Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Barnes, David Weninger,Rigel, Dean Franklin

申请号：

AU2014216417

公开号：

AU2014216417A1

申请日:

2014.02.12

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

The present invention provides a compound of formula (I)； or a pharmaceutically acceptable salt thereof, wherein X is defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/